Search
for
Sort by
Research 631–660 of 1000+
- AN UPDATE ON ETIOPATHOGENESIS AND MANAGEMENT OF ALOPECIA
- LB789 Novel IFNγ aptamer TAGX-0003 protected hair follicles from immune privilege collapse and reversed Alopecia Areata like phenotype in humanized mouse model
- 917 Frontal fibrosing alopecia scalp profiling links Th1/Th2 and JAK3 activation with fibrosis and loss of follicular stem cells
- A Story About Hair
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Assessing the Efficacy of Monthly 308 nm Excimer Lamp Double-Stacked Pulse Adjusted Therapy for Alopecia Areata
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Research Progress on the Application of Stem Cells in Hair Regeneration
- Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Baricitinib: A Review in Severe Alopecia Areata
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience
- The autoimmune basis of alopecia areata: A comprehensive review
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- JAK inhibitors in dermatology: The promise of a new drug class
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- Therapeutic Response of Alopecia Areata‐Associated Nail Changes to Baricitinib
- Ruxolitinib found to cause eyelash growth: a case report
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives